The Cardiac Amyloidosis and Cardiomyopathy Center, located at the hospital, will focus on diagnosing patients with rare amyloid conditions earlier and providing personalized treatment, a Nov. 17 news release from the health system said.
Amyloidosis is a rare condition caused by an abnormal protein that accumulates in organs which is often misdiagnosed due to its subtle symptoms. At least one type of the amyloidosis can be fatal in six months, according to the release.
The center will include a range of disciplines, such as cardiology, neurology, hematology, nephrology, pathology and bone marrow transplantation.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
